How Often Should You Get Blood Work on TRT?

What is the standard TRT monitoring schedule?

The Endocrine Society and American Urological Association both recommend a front-loaded monitoring pattern: frequent testing in the first year when your body is adjusting to testosterone therapy, then less frequent testing once your protocol is stable. The core schedule is baseline (pre-TRT), 6-8 weeks, 3 months, 6 months, 12 months, then every 6-12 months ongoing. This structure balances safety with practicality — catching dose-response issues and side effects early without subjecting stable patients to unnecessary draws.

What should your first labs on TRT check?

Your first lab draw after starting TRT should happen at 6-8 weeks. This timing matters: testosterone cypionate and enanthate (the most common injectable formulations) have half-lives of approximately 8 days. Steady-state blood levels are reached after about 5 half-lives, or roughly 5-6 weeks. Testing before this point captures transitional levels that will continue to change, making the results misleading for dose adjustment decisions.

The 6-8 week panel should include total testosterone, free testosterone, estradiol (sensitive assay), CBC (for hematocrit and hemoglobin), and a comprehensive metabolic panel. This draw tells your provider whether the starting dose is producing target testosterone levels, whether estradiol is rising proportionally or excessively, and whether hematocrit has begun to climb.

What does the first-year monitoring timeline look like?

The first year is the most lab-intensive period of TRT. Your body is adjusting, your provider is titrating the dose, and the markers most affected by testosterone — hematocrit, estradiol, lipids — are in flux. Here is the standard first-year schedule.

If your provider adjusts your dose at any point during the first year, the 6-8 week clock resets. Each dose change requires a new follow-up draw to assess the response. This is true for any change — increasing the dose, decreasing it, switching delivery methods, or altering injection frequency.

What monitoring is needed after the first year?

Once you have been on a stable dose for at least six months with consistent, in-range lab results and no concerning trends, most providers shift to a 6-12 month monitoring schedule. The annual panel should be comprehensive: total testosterone, free testosterone, estradiol (sensitive), CBC with hematocrit, CMP, lipid panel, PSA (men over 40), and SHBG.

Some providers are comfortable with annual-only testing for long-term stable patients. Others prefer semi-annual checks. The right frequency depends on your specific situation — a man with a history of borderline hematocrit elevation should check more often than one whose hematocrit has been flat at 46% for three years.

Hematocrit deserves special emphasis. Even after years on a stable protocol, hematocrit can continue to rise gradually. It should be checked at every lab draw, regardless of the overall monitoring frequency. For a deep dive into hematocrit management, see our hematocrit on TRT guide.

When should you get unscheduled blood work?

Several situations warrant blood work outside the standard schedule. Do not wait for your next scheduled draw if any of these apply.

• New or worsening symptoms: If you develop symptoms suggestive of high estradiol (water retention, nipple sensitivity, mood swings), low estradiol (joint pain, fatigue, low libido), or high hematocrit (headaches, facial flushing, shortness of breath), get labs to confirm before making changes.
• After a dose or protocol change: Wait 6-8 weeks, then draw. This applies to dose increases, dose decreases, switching from injections to topical, or changing injection frequency.
• After starting a new medication: Opioids, corticosteroids, some antidepressants, and other medications can affect testosterone, SHBG, and liver function. Check labs 6-8 weeks after starting any medication that may interact.
• After significant body composition changes: Gaining or losing 15+ pounds can alter aromatization rates, SHBG levels, and insulin sensitivity — all of which affect your TRT response.
• After therapeutic phlebotomy: Recheck hematocrit 4-6 weeks after blood donation or phlebotomy to confirm it dropped sufficiently.

Which markers do you need at each stage?

Not every draw needs to be a full panel. Here is a practical breakdown of minimum and expanded panels for each monitoring phase.

Minimum draw (routine check): Total testosterone, hematocrit, estradiol (sensitive). This covers the three markers most likely to change and drive protocol adjustments. Cost-effective for mid-cycle checks between comprehensive panels.

Standard draw (quarterly/semi-annual): Add free testosterone, CBC with differential, and CMP. This provides a more complete picture of your response and organ function.

Comprehensive draw (annual): Full panel including everything above plus lipids, PSA, SHBG, HbA1c, and any other markers your provider tracks. This is your full-system check.

Does monitoring differ by delivery method?

The core monitoring schedule is the same regardless of delivery method, but draw timing differs. For injectable testosterone (cypionate or enanthate), blood is typically drawn at trough — the morning of your next scheduled injection, before you inject. This ensures you are assessing your minimum level.

For transdermal testosterone (gels, creams), draw timing depends on what your provider wants to assess. A peak measurement is drawn 2-4 hours after application. A trough measurement is drawn before the next application. Most providers prefer trough for ongoing monitoring.

For testosterone pellets (Testopel), monitoring should occur 4-6 weeks post-insertion (peak assessment) and then every 3-4 months to determine when levels begin to decline and reinsertion is needed. Pellet patients often need fewer total draws per year since the delivery is continuous.

How can you manage monitoring costs?

Regular blood work adds up, especially if you are paying out of pocket. Several strategies keep costs manageable without compromising safety.

• Use direct-to-consumer platforms: Services like DiscountedLabs and Marek Health offer TRT-specific panels at $75-150 — significantly less than a la carte lab pricing. See our testing options guide for detailed comparisons.
• Ask for standing orders: Some providers issue standing lab orders that let you draw blood whenever you need without a new appointment. This saves the cost of an office visit per draw.
• Use insurance strategically: If you have insurance, your provider-ordered annual comprehensive panel is likely covered. Use out-of-pocket services for the interim checks between insurance-covered draws.
• Batch smartly: If your protocol is stable, consider doing one comprehensive annual draw through insurance and one mid-year minimum panel out of pocket — two draws per year covering the essentials without overloading costs.

For the complete breakdown of every marker in your panel and what each one means, return to the complete TRT blood work guide.